Articles tagged "Outcome"

2019 American Transplant Congress
500 Pediatric Liver Transplants At A Freestanding Pediatric Hospital – Where It Is Done Best
A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss
Baylor College of Medicine, Houston, TX
*Purpose: Our institution, a freestanding pediatric hospital (FPH) has a large pediatric liver transplant (LT) experience. Our aim was to analyze our experience with other…
2019 American Transplant Congress
The Role of Non-Traditional Environmental Factors in Long-Term Outcomes of Liver Transplantation
J. Buggs¹, D. Patino², B. Evans¹, C. Anderson¹, C. Delfavero¹, E. Rogers¹, A. Alsina¹, A. Kumar³
¹Tampa General Hospital, Tampa, FL, ²University of Tampa, Tampa, FL, ³University of South Florida, Tampa, FL
*Purpose: The purpose of this research project was to evaluate the role of non-traditional subjective environmental factors in long-term outcomes of liver transplantation.*Methods: We conducted…
2019 American Transplant Congress
Kidney Allograft Survival Among Kidney-pancreas Recipients Compared To Solitary Kidney Recipients: A Mate Analysis Of The Unos/optn Database
O. K. Serrano¹, R. Kandaswamy², E. B. Finger²
¹Hartford Hospital, Hartford, CT, ²Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Deceased donor kidney allocation policies differ between solitary organs and combined transplants. The estimated waiting time for a kidney as part of a simultaneous…
2019 American Transplant Congress
Allograft Survival is Influenced by Gut Microbiota-Dependent Modulation of Innate Immunity
V. Saxena¹, Y. Xiong¹, L. Hittle¹, L. Li¹, T. Simon², W. Piao¹, C. C. Brinkman¹, E. M. Smyth¹, T. Zhang¹, C. Wagner¹, C. M. Palusckievicz¹, W. F. Fricke³, E. F. Mongodin¹, J. S. Bromberg¹
¹U Maryland, Baltimore, MD, ²Institut de Pharmacologie Moléculaire et Cellulaire, Université Côte d’Azur, CNRS, Valbonne, France, ³Institute of Biological Chemistry and Nutrition, U Hohenheim, Stuttgart, Germany
*Purpose: The gut microbiota driven inflammatory response and the host immune system engage bidirectional regulation of each other. These interactions are poorly characterized in organ…
2019 American Transplant Congress
Outcomes in Non-A1 and Non A1 B to B Deceased Donor Renal Transplantation Are Comparable to B Donor Renal Transplants
A. Brar, L. Kwon, A. Gruessner, F. Tedla, R. Gruessner, N. Sumrani, D. John, J. Renz, M. O. Salifu
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Blood type B patients wait longer to get deceased donor (DD) renal transplants compared to other blood types. On December 2014, the US national…
2019 American Transplant Congress
Kidney Donor Outcomes ≥ 50 Years Post Donation
D. Keys, S. Jackson, A. Matas
University of Minnesota, Minneapolis, MN
*Purpose: Data on true long-term follow-up (LTFU) of living kidney donors (LD) is sparse. Given this, the acceptance of young donors can be a challenging…
2019 American Transplant Congress
Multi-Organ Transplant Results in Lower Patient and Graft Survival Than Kidney Alone Transplant
C. A. Custer¹, J. Entwistle², K. Ladin³, L. Cartwright¹, E. J. Gordon⁴
¹United Network for Organ Sharing, Richmond, VA, ²Thomas Jefferson University, Washington, DC, ³Tufts University, Medford, MA, ⁴Northwestern University, Chicago, IL
*Purpose: Kidneys are the most common organ involved in multi-organ transplants (MOT). MOT candidates often receive priority access to kidneys over single organ transplant (SOT)…
2019 American Transplant Congress
Renal Outcomes from Expander-1: Pilot Study of HCV+ Donor Kidneys for HCV- Kidney Recipients
S. Thaduri¹, C. Durand¹, N. Desai², D. Segev², N. Bair¹, D. Brown¹, F. F. Naqvi¹
¹Medicine, -Johns Hopkins University, -Baltimore, MD, ²Surgery, -Johns Hopkins University, -Baltimore, MD
*Purpose: Direct acting antivirals (DAAs) have led to high cure rates (>95%) for hepatitis C. Utilization of HCV+ donor kidneys for patients with advanced kidney…
2019 American Transplant Congress
Estimated vs. Actual Graft Failure and Patient Survival after Kidney Transplantation
J. Buggs¹, T. Thigpen², E. Rogers¹, A. Kumar³, V. Bowers¹
¹Tampa General Hospital, Tampa, FL, ²Wesleyan College, Macon, GA, ³University of South Florida, Tampa, FL
*Purpose: The purpose of this study was to examine the difference between the estimated and actual values of graft survival and patient survival in kidney…
2019 American Transplant Congress
Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation
S. Ries,¹, N. J. Skill¹, E. Campbell¹, R. Daniel², C. A. Kubal¹, M. S. Richard¹, M. A. Maluccio¹
¹Surgery, Indiana University, Indianapolis, IN, ²University of Washington, Seattle, WA
*Purpose: Sarcopenia is defined as the loss of muscle mass, typically associated with aging, but frequently appearing in liver disease patients. In particular, sarcopenia present…